TJM Labs raises $100.0M Series B (United States, Jul 2026)
$100.0M
$100 millionGenerated social card
Headline
TJM Labs Reveals $100 Million Raised Across Three Rounds, 450+ Live Pharmacies, And Two Acquisitions - Pulse 2.0
About
TJM Labs is a pharmacy AI platform that automates operational workflows for pharmacies. It targets pharmacies by providing solutions that streamline tasks such as prescription intake and data entry, significantly improving efficiency. The company has raised $100 million across three funding rounds and is now operational in over 450 pharmacies.
Article summary
TJM Labs Reveals $100 Million Raised Across Three Rounds, 450+ Live Pharmacies, And Two Acquisitions Pulse 2.0
Founder
Jonathan Adly
Founder and CEO
Investors · 3
1 hiddenRelated rounds
| Aug 14, 2026 | MiiHealth AI | $2.8M | — | United States |
| Aug 14, 2026 | Alloy Robotics | $8.0M | Pre-seed | United States |
| Aug 14, 2026 | Zipline | $950.0M | Debt | United States |
| Aug 14, 2026 | InduPro | $77.0M | Series B | United States |